![]() Nat Neurosci 3:537–544īock C, Kiskinis E, Verstappen G, Gu H, Boulting G, Smith ZD, Ziller M, Croft GF, Amoroso MW, Oakley DH, Gnirke A, Eggan K, Meissner A (2011) Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. J Clin Invest 79:801–812ījorklund A, Lindvall O (2000) Cell replacement therapies for central nervous system disorders. Evidence for a functionally significant subendothelial matrix in normal rat liver. Nat Protoc 7:2029–2040īissell DM, Arenson DM, Maher JJ, Roll FJ (1987) Support of cultured hepatocytes by a laminin-rich gel. Trends Genet 32:29–41īeers J, Gulbranson DR, George N, Siniscalchi LI, Jones J, Thomson JA, Chen G (2012) Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions. Stem Cells 26:2300–2310īecker JS, Nicetto D, Zaret KS (2016) H3K9me3-dependent heterochromatin: barrier to cell fate changes. Diabetologia 55:358–371īauwens CL, Peerani R, Niebruegge S, Woodhouse KA, Kumacheva E, Husain M, Zandstra PW (2008) Control of human embryonic stem cell colony and aggregate size heterogeneity influences differentiation trajectories. Cell Stem Cell 9:17–23īasford CL, Prentice KJ, Hardy AB, Sarangi F, Micallef SJ, Li X, Guo Q, Elefanty AG, Stanley EG, Keller G, Allister EM, Nostro MC, Wheeler MB (2012) The functional and molecular characterisation of human embryonic stem cell-derived insulin-positive cells compared with adult pancreatic beta cells. Lancet Neurol 12:84–91īar-Nur O, Russ HA, Efrat S, Benvenisty N (2011) Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell 15:539–542īarker RA, Barrett J, Mason SL, Bjorklund A (2013) Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson’s disease. PLoS One 11:e0151264īarker RA (2014) Developing stem cell therapies for Parkinson’s disease: waiting until the time is right. ![]() Stem Cell Rep 4:967–974īadenes SM, Fernandes TG, Cordeiro CS, Boucher S, Kuninger D, Vemuri MC, Diogo MM, Cabral JM (2016) Defined essential 8 medium and vitronectin efficiently support scalable xeno-free expansion of human induced pluripotent stem cells in stirred microcarrier culture systems. Methods Mol Biol 767:147–159Īvior Y, Biancotti JC, Benvenisty N (2015) TeratoScore: assessing the differentiation potential of human pluripotent stem cells by quantitative expression analysis of teratomas. Cell 145:183–197Īusubel LJ, Lopez PM, Couture LA (2011) GMP scale-up and banking of pluripotent stem cells for cellular therapy applications. Methods Mol Biol 1502:53–61Īmit M, Itskovitz-Eldor J (2012) Atlas of human pluripotent stem cells: derivation and culturing, New York, Humana Press.Īng YS, Tsai SY, Lee DF, Monk J, Su J, Ratnakumar K, Ding J, Ge Y, Darr H, Chang B, Wang J, Rendl M, Bernstein E, Schaniel C, Lemischka IR (2011) Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network. Hum Mol Genet 13:601–608Īggarwal VK, Goyal N, Deirmengian G, Rangavajulla A, Parvizi J, Austin MS (2014) Revision total knee arthroplasty in the young patient: is there trouble on the horizon? J Bone Joint Surg Am 96:536–542Īlmutawaa W, Rohani L, Rancourt DE (2016) Expansion of human induced pluripotent stem cells in stirred suspension bioreactors. Abeyta MJ, Clark AT, Rodriguez RT, Bodnar MS, Pera RA, Firpo MT (2004) Unique gene expression signatures of independently-derived human embryonic stem cell lines.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |